These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26015420)

  • 1. Exit-site infection and acute peritonitis due to peritoneal dialysis catheter rupture.
    Knehtl M; Ekart R; Bevc S; Horvat M; Hojs R
    Perit Dial Int; 2015; 35(3):362-3. PubMed ID: 26015420
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
    Ritzau J; Hoffman RM; Tzamaloukas AH
    Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis.
    Lew SQ; Gruia A
    Perit Dial Int; 2013; 33(1):101-2. PubMed ID: 23349200
    [No Abstract]   [Full Text] [Related]  

  • 4. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.
    Thodis E; Passadakis P; Ossareh S; Panagoutsos S; Vargemezis V; Oreopoulos DG
    Int J Artif Organs; 2003 Aug; 26(8):698-714. PubMed ID: 14521167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of methods to prevent peritoneal dialysis catheter infections.
    Piraino B; Bernardini J; Bender FH
    Perit Dial Int; 2008; 28(5):437-43. PubMed ID: 18708532
    [No Abstract]   [Full Text] [Related]  

  • 6. Can we reduce rates of Staphylococcus aureus and other peritonitis in peritoneal dialysis patients?
    Piraino B
    Perit Dial Int; 2010; 30(3):277-9. PubMed ID: 20424197
    [No Abstract]   [Full Text] [Related]  

  • 7. [The microbial pattern of the catheter exit-site infection in peritoneal dialysis: A non-diphtheria Corynebacteria emergence?].
    Teixidó J; Arias N; Tarrats L; Romero R
    Nefrologia; 2007; 27(3):350-8. PubMed ID: 17725455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of peritonitis after an exit site infection: a time-matched, case-control study.
    Lloyd A; Tangri N; Shafer LA; Rigatto C; Perl J; Komenda P; Sood MM
    Nephrol Dial Transplant; 2013 Jul; 28(7):1915-21. PubMed ID: 23382265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of exit site care as peritonitis prophylaxis: experience in our centre].
    Conde Rivera O; Santos Nores J; Borrajo Prol M; Pérez Melón C
    Nefrologia; 2010; 30(5):589-91. PubMed ID: 20882098
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A five-year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis.
    Piraino B; Bernardini J; Sorkin M
    Am J Kidney Dis; 1987 Oct; 10(4):281-6. PubMed ID: 3661549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for peritoneal dialysis-related infections.
    Oxton LL; Zimmerman SW; Roecker EB; Wakeen M
    Perit Dial Int; 1994; 14(2):137-44. PubMed ID: 8043666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
    J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
    Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C
    Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal catheter exit-site and tunnel infections.
    Piraino B
    Adv Ren Replace Ther; 1996 Jul; 3(3):222-7. PubMed ID: 8827201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus nasal carriage is not associated with an increased incidence of exit-site infection with the same organism.
    Twardowski ZJ; Prowant BF
    Perit Dial Int; 1993; 13 Suppl 2():S306-9. PubMed ID: 8399594
    [No Abstract]   [Full Text] [Related]  

  • 19. A contemporary approach to the prevention of peritoneal dialysis-related peritonitis in children: the role of improvement science.
    Redpath Mahon A; Neu AM
    Pediatr Nephrol; 2017 Aug; 32(8):1331-1341. PubMed ID: 27757588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of peritonitis.
    Piraino B
    Perit Dial Int; 1998; 18(3):244-6. PubMed ID: 9663885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.